Sendai virus-based liposomes enable targeted cytosolic delivery of nanoparticles in brain tumor-derived cells
Autor: | Veronica Rotari, Maribel Vazquez, Veronica Dudu |
---|---|
Rok vydání: | 2012 |
Předmět: |
lcsh:Medical technology
lcsh:Biotechnology EGFR Cell Biomedical Engineering Brain tumor Pharmaceutical Science Medicine (miscellaneous) Bioengineering 02 engineering and technology Stem cell marker Sendai virus Applied Microbiology and Biotechnology 03 medical and health sciences lcsh:TP248.13-248.65 Tumor Cells Cultured medicine cancer Humans Progenitor cell 030304 developmental biology 0303 health sciences Liposome biology Quantum dots Brain Neoplasms Research 021001 nanoscience & nanotechnology biology.organism_classification medicine.disease Immunohistochemistry Molecular biology 3. Good health ErbB Receptors Virus-based liposomes medicine.anatomical_structure lcsh:R855-855.5 Microscopy Fluorescence Liposomes Cancer cell Cancer research Nanoparticles Molecular Medicine Glioblastoma 0210 nano-technology Intracellular Medulloblastoma |
Zdroj: | Journal of Nanobiotechnology Journal of Nanobiotechnology, Vol 10, Iss 1, p 9 (2012) |
ISSN: | 1477-3155 |
Popis: | Background Nanotechnology-based bioassays that detect the presence and/or absence of a combination of cell markers are increasingly used to identify stem or progenitor cells, assess cell heterogeneity, and evaluate tumor malignancy and/or chemoresistance. Delivery methods that enable nanoparticles to rapidly detect emerging, intracellular markers within cell clusters of biopsies will greatly aid in tumor characterization, analysis of functional state and development of treatment regimens. Results Experiments utilized the Sendai virus to achieve in vitro, cytosolic delivery of Quantum dots in cells cultured from Human brain tumors. Using fluorescence microscopy and Transmission Electron Microscopy, in vitro experiments illustrated that these virus-based liposomes decreased the amount of non-specifically endocytosed nanoparticles by 50% in the Human glioblastoma and medulloblastoma samples studied. Significantly, virus-based liposome delivery also facilitated targeted binding of Quantum dots to cytosolic Epidermal Growth Factor Receptor within cultured cells, focal to the early detection and characterization of malignant brain tumors. Conclusions These findings are the first to utilize the Sendai virus to achieve cytosolic, targeted intracellular binding of Qdots within Human brain tumor cells. The results are significant to the continued applicability of nanoparticles used for the molecular labeling of cancer cells to determine tumor heterogeneity, grade, and chemotherapeutic resistivity. |
Databáze: | OpenAIRE |
Externí odkaz: |